Faculty profile

Neil Vasdev

ResearcherUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses may be missing. Find their university profile.

Neil Vasdev

Researcher

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
55 publications in the last five years, latest in 2026.
Senior (last) author on 29 recent papers, a sign of leading a research group.
Principal investigator on 3 research grants (2 CIHR, 1 NSERC), most recently in 2023.
Supervisor on 5 trainee awards (5 CIHR), most recently in 2023.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

114

Publications

229

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Crc

Latest papers

Assessment of noninvasive quantification of [18F]SynVesT-1 with simplified reference tissue model 2 in an adolescent and youth cohort
European Journal of Nuclear Medicine and Molecular Imaging · 2026
Loss of vesicular monoamine transporter 2 in striatum of long COVID and relationship to neuropsychiatric symptoms.
EBioMedicine · 2026
PET imaging of alpha-synuclein: from radiotracer design through in vitro and in vivo translation.
European journal of nuclear medicine and molecular imaging · 2026 · senior author

All 114 publications

Latest funding

Develop in vivo PET imaging probes for imaging AMPA receptor in multiple sclerosis
CIHR · 2026 · Co-investigator
$849,150
Development of in vivo PET imaging methods using SV2A PET to evaluate synapse damages in multiple sclerosis
CIHR · 2025 · Co-investigator
$711,450
The role of the endocannabinoid 2AG in high dopamine states: implications of pharmacological manipulation
CIHR · 2025 · Co-investigator
$921,826

All 31 grants and awards

114 publications.

Assessment of noninvasive quantification of [18F]SynVesT-1 with simplified reference tissue model 2 in an adolescent and youth cohort

Uribe C, Narciso L, Cho SS, Zilberman M, Cote C, Yu L, Truong J, Dickie E, Nikolova Y, Voineskos A

European Journal of Nuclear Medicine and Molecular Imaging20261 citations

DOI: 10.1007/s00259-026-07818-1

Loss of vesicular monoamine transporter 2 in striatum of long COVID and relationship to neuropsychiatric symptoms.

Liu YK, Persaud D, Vieira EL, Braga J, Rusjan P, Miler L, Rabin JS, McCluskey T, Boileau I, Chao T, Bagby M, Narciso L, Gray LR, Vasdev N, Desmond K, Kloiber S, Warsh J, Husain MI, Smart K, Wang W, Meyer JH

EBioMedicine2026

DOI: 10.1016/j.ebiom.2026.106339 PMID: 42431745

PET imaging of alpha-synuclein: from radiotracer design through in vitro and in vivo translation.

Pees A, Grotegerd AK, Bleher D, Herfert K, Vasdev N

European journal of nuclear medicine and molecular imaging2026Senior author

DOI: 10.1007/s00259-025-07695-0 PMID: 41559331

Autoradiography and preclinical PET studies with radiolabeled asyn-44 and ACI-12589 for imaging α-synuclein.

Varlow C, Pees A, Stehouwer JS, Grotegerd AK, Bleher D, Guarino DS, Lindberg A, Tong J, Lopresti BJ, Knight AC, Zabrocki M, Nasser A, Shalgunov V, Ferri E, Cannazza G, McQuade P, Mathis CA, Mach RH, Battisti UM, Herfert K, Herth MM, Knudsen GM, Vasdev N

Journal of Parkinson's disease2026Senior author

DOI: 10.1177/1877718x261431108 PMID: 41995458

25 Years of "Loop" Radiochemistry for PET Imaging.

Murrell E, Khan S, Vasdev N

Journal of labelled compounds & radiopharmaceuticals2026Senior author

DOI: 10.1002/jlcr.70029 PMID: 41975656

Tau-PET imaging and blood biomarkers reveal early tauopathy in special operations forces exposed to repetitive blast.

Lora SJ, Rhind SG, Watling SE, Narciso L, Warsh J, Vartanian O, McCluskey T, Tyndale RF, Tartaglia MC, Shiu MY, Vallée I, Crouzat M, Vergie I, Vasdev N, Boileau I

Brain communications2026

DOI: 10.1093/braincomms/fcag070 PMID: 41853047

SV2A PET reveals synaptic density loss in experimental autoimmune encephalomyelitis and in a pilot multiple sclerosis study.

Chia PHJ, Toyonaga T, Tong J, Le H, Dias M, Boyle AJ, Raymond R, Longbrake EE, Huang Y, Carson RE, Airas L, Vasdev N, Chen MK, Zheng C

Proceedings of the National Academy of Sciences of the United States of America2026

DOI: 10.1073/pnas.2517709123 PMID: 41774796

Toward First-in-Class Brain PET Tracers for Imaging TDP-43 Pathology.

Liang SH, Wang R, Ran C, Vasdev N, Li Y

Chemical & biomedical imaging2026

DOI: 10.1021/cbmi.6c00041 PMID: 42657103

Three-component synthesis of β-thio tertiary alkylamines from simple alkenes via SH2 homolytic substitution.

Wang H, Wang T, Li Y, He Q, Ma W, Guan X, Li Y, Bao Y, Zhao Y, Zhang Q, Vasdev N, Zheng C, Fu J

Science advances2026

DOI: 10.1126/sciadv.adz1874 PMID: 41512059

Advancing biomarker development for chronic traumatic encephalopathy: Summary and recommendations from the 2025 Leon Thal Summit.

Bernick C, Kleven BC, Alosco ML, Arciniega H, Ashton N, Bender A, Bieniek KF, Cordes D, Cordes L, Katz DI, Keene D, Kinney J, Mandarino L, Matthews D, McKee A, Mez J, Oh EC, Peskind E, Rabinovici GD, Reiman EM, Stern RA, Vasdev N, Zetterberg H, Zhuang X, Cummings JL

Alzheimer's & dementia : the journal of the Alzheimer's Association2026

DOI: 10.1002/alz.71424 PMID: 42121201

Something wrong or missing on this profile? Suggest a correction

Neil Vasdev

Research

Latest papers

Latest funding

Assessment of noninvasive quantification of [18F]SynVesT-1 with simplified reference tissue model 2 in an adolescent and youth cohort

Loss of vesicular monoamine transporter 2 in striatum of long COVID and relationship to neuropsychiatric symptoms.

PET imaging of alpha-synuclein: from radiotracer design through in vitro and in vivo translation.

Autoradiography and preclinical PET studies with radiolabeled asyn-44 and ACI-12589 for imaging &#x3b1;-synuclein.

25 Years of "Loop" Radiochemistry for PET Imaging.

Tau-PET imaging and blood biomarkers reveal early tauopathy in special operations forces exposed to repetitive blast.

SV2A PET reveals synaptic density loss in experimental autoimmune encephalomyelitis and in a pilot multiple sclerosis study.

Toward First-in-Class Brain PET Tracers for Imaging TDP-43 Pathology.

Three-component synthesis of &#x3b2;-thio tertiary alkylamines from simple alkenes via SH2 homolytic substitution.

Advancing biomarker development for chronic traumatic encephalopathy: Summary and recommendations from the 2025 Leon Thal Summit.

Frequent collaborators

Isabelle Boileau

Kelly Smart

Pablo Rusjan

Wei Wang

Chao Zheng

Stefan Kloiber

Khunsa Faiz

Fang Liu

Meng-Chuan Lai

Wanda Tempelaar

Alexia Polillo

Daniel Felsky

Hsiang-Yuan Lin

Martin Rotenberg

Nicole Kozloff

Christin Schifani

Peter Szatmari

Katherine Zukotynski

George Foussias

Mark Nitz

Nathan Kolla

Ariel Graff-Guerrero

Joanne McLaurin

Kristin Cleverley

Pedro Rosa-Neto

Erica Vieira

Tristan Glatard

Yona Lunsky

Sanjeev Kumar

Philip Gerretsen

Frank Wuest

Shelley McMain

Stephanie Ameis

Robin Green

Claire de Oliveira

Aristotle Voineskos

Ruth Ross

Yona Lunsky

Mario Masellis

Peter Szatmari

Autoradiography and preclinical PET studies with radiolabeled asyn-44 and ACI-12589 for imaging α-synuclein.

Three-component synthesis of β-thio tertiary alkylamines from simple alkenes via SH2 homolytic substitution.